BISON CAPITAL ACQUISITION CORP. ANNOUNCES CLOSING OF ITS BUSINESS COMBINATION WITH XYNOMIC PHARMACEUTICALS, INC.

15 May 2019 - Yahoo News
Bison Capital Acquisition Corp. (BCAC) (“BCAC” or the “Company”) today announced that it has closed its business combination with Xynomic Pharmaceuticals, Inc. (“Xynomic”), a Delaware corporation, pursuant to which Xynomic became a wholly-owned subsidiary of BCAC. In connection with the business combination, ...
usx:bcac

---

Bison Capital Acquisition Corp. Announces the Postponement of the Meeting Date for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc.

3 May 2019 - Yahoo News
NEW YORK, NY and SHANGHAI, CHINA, May 03, 2019 (GLOBE NEWSWIRE) -- The special meeting (the “Special Meeting”) of shareholders of Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC), originally scheduled to be held on May 13, 2019 at 9:00 a.m., Beijing Time (May 12, 2019 at 9:00 p.m. Eastern Daylight ...
usx:bcac

---

Bison Capital Acquisition Corp. Announces Record and Meeting Dates for the Special Meeting of Shareholders to Approve Business Combination with Xynomic Pharmaceuticals, Inc.

29 Apr 2019 - Yahoo News
Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC) announced today, that it has established a record date of April 5, 2019 for a special meeting of its shareholders to be held on May 13, 2019 at 9:00 a.m., Beijing Time (the “Special Meeting”) to consider and approve the agreement and plan of merger, ...
usx:bcac

---

Xynomic Pharmaceuticals, Inc. Will Present at ASCO 2019 Annual Meeting, Will Sponsor an EU Investigator Meeting for Potentially Pivotal Kidney Cancer Trial, and Appoints Interim Chief Accounting Officer

20 Mar 2019 - Yahoo News
RALEIGH, N.C. and SHANGHAI , March 20, 2019 /PRNewswire/ -- Xynomic Pharmaceuticals, Inc. ("Xynomic"), a clinical stage US-China oncology drug development company, and Bison Capital Acquisition ...
usx:bcac

---

Xynomic Pharma Achieves Important Regulatory Milestones in China and EU in Potentially Pivotal Kidney Cancer and Lymphoma Trials

16 Mar 2019 - Yahoo News
RALEIGH, N.C. and SHANGHAI , March 16, 2019 /PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC), today jointly ...
usx:bcac

---

Xynomic Pharma Doses First South Korean Patient in Phase 3 Renal Cell Carcinoma Trial and Hires Senior Executive Dr. Sophia Paspal to Head Regulatory Affairs and Quality Assurance

23 Feb 2019 - Yahoo News
RALEIGH, N.C. and SHANGHAI , Feb. 23, 2019 /PRNewswire/ -- Xynomic Pharma, a clinical stage US-China oncology drug development company, and Bison Capital Acquisition Corp. (Nasdaq: BCAC), today jointly ...
usx:bcac

---

Bison Capital Acquisition Corp. Clarifies Information of Its Chairman and President

18 Oct 2018 - Yahoo News
Bison Capital Acquisition Corp. (“BCAC”, NASDAQ: BCAC) today issued an announcement in order to clarify some information regarding its Chairman and President, Mr. Peixin Xu (spelled “徐沛欣” in Chinese and hereafter referred to as “BCAC’s Chairman”). Because there has been some confusion in the public ...
usx:bcac

---

Who Are The Top Investors In Bison Capital Acquisition Corp (NASDAQ:BCAC)?

7 Jun 2018 - Yahoo News
In this analysis, my focus will be on developing a perspective on Bison Capital Acquisition Corp’s (NASDAQ:BCAC) latest ownership structure, a less discussed, but important factor. Ownership structure has beenRead More...
usx:bcac

---

Who Owns Most Of Bison Capital Acquisition Corp (NASDAQ:BCAC)?

2 Mar 2018 - Yahoo News
In this analysis, my focus will be on developing a perspective on Bison Capital Acquisition Corp’s (NASDAQ:BCAC) latest ownership structure, a less discussed, but important factor. Ownership structure of aRead More...
usx:bcac

---

Interested In Financials? Why Bison Capital Acquisition Corp (BCAC) May Be The Entry Point

29 Nov 2017 - Yahoo News
Bison Capital Acquisition Corp (NASDAQ:BCAC), a USD$23.53M small-cap, is a capital market firm operating in an industry, which has recently been facing serious existential threats resulting from potential disintermediation andRead More...
usx:bcac

---